<b>Purpose:</b> To identify outpatient treatment patterns of patients with exudative age-related macular degeneration (AMD) who received approved anti-vascular endothelial growth factor (VEGF) therapy, using real-world data from hospitals in Japan. This evidence concerns the gene VEGFA and age-related macular degeneration.